Targinta AB
559157-6698ActiveDeveloping targeted antibodies and ADCs for aggressive cancers.
Overview
- 0
- Employees
- ≤1K SEK
- Revenue
- 2018
- Founded
Key Decision Makers
Evy Lundgren-Åkerlund
CEO
Description
Targinta AB is a Swedish biotechnology company focused on developing novel treatments for aggressive and life-threatening cancers. The company specializes in creating targeted, toxin-armed antibodies, known as Antibody-Drug Conjugates (ADCs), and functional blocking antibodies. Their entire product...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Bioteknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559157669801
Decision Makers
1 contacts in FunnelfeedrEvy Lundgren-Åkerlund
CEO
Similar Companies
20 similar companies in FunnelfeedrXintela AB
10–19 employeesDeveloping stem cell and targeted cancer therapies for unmet needs.
Ascelia Pharma AB
Biotech developing novel orphan oncology drugs for unmet needs.
BioInvent International Aktiebolag
100–199 employeesClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Ascelia Incentive AB
0 employeesBiotech developing novel orphan oncology drugs for unmet medical needs.
Affibody Medical AB
Developing next-generation radiopharmaceuticals using proprietary Affibody platform.
Browse More
Targinta AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo